93587-23-6 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
7-BROMO-1,5-DIHYDRO-4H-PYRROLO[3,2-D]PYRIMIDIN-4-ONE is utilized as a building block for the synthesis of novel compounds with potential biological activity. Its unique structure and potential therapeutic uses make it a valuable asset for researchers in the field of medicinal chemistry and drug discovery.
Used in Medicinal Chemistry:
In the realm of medicinal chemistry, 7-BROMO-1,5-DIHYDRO-4H-PYRROLO[3,2-D]PYRIMIDIN-4-ONE is employed as a key component in the design and synthesis of new pharmaceutical agents. Its properties may contribute to the development of innovative therapeutics with improved efficacy and selectivity.
Used in Drug Discovery:
7-BROMO-1,5-DIHYDRO-4H-PYRROLO[3,2-D]PYRIMIDIN-4-ONE serves as a valuable tool in drug discovery processes, where its potential biological activities are explored and harnessed to create new drugs with specific therapeutic targets.
Check Digit Verification of cas no
The CAS Registry Mumber 93587-23-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,3,5,8 and 7 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 93587-23:
(7*9)+(6*3)+(5*5)+(4*8)+(3*7)+(2*2)+(1*3)=166
166 % 10 = 6
So 93587-23-6 is a valid CAS Registry Number.
93587-23-6Relevant academic research and scientific papers
New Enzyme Inhibitor Compounds
-
Paragraph 0271; 0272, (2013/05/08)
Disclosed are compounds which inhibit SSAO enzyme activity. Also disclosed are pharmaceutical compositions comprising these compounds and the use of these compounds in the treatment or prevention of medical conditions wherein inhibition of SSAO activity is beneficial, such as inflammatory diseases, immune disorders and the inhibition of tumour growth.
NEW ENZYME INHIBITOR COMPOUNDS
-
, (2011/10/10)
Compounds of formula (I) are inhibitors of Semicarbazide-sensitive amine oxidase wherein R1, A, X and R2 are as defined in the claims.
GLUCOCORTICOID MIMETICS, METHODS OF MAKING THEM, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
-
Page/Page column 152-153, (2008/12/06)
Compounds of Formula (IA) (IA), and Formula (IB) (IB), wherein R1, R2, R3, A, B, C, D, E, G, X, Y, and Z are as defined herein, or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.
